Research and Policy Priorities
The evidence reviewed in this chapter documents what is known about healthcare system failures in ME/CFS. But the knowledge is overwhelmingly descriptive β it documents problems, not solutions. The following structured inventory identifies the evidence gaps that must be filled before policy reform can be evidence-based rather than aspirational:
Comparative care models: No RCT or controlled comparison of specialist clinic versus primary care; no study of whether specialist clinics improve outcomes.
Guideline implementation: No audit mechanism measuring whether physicians follow NICE 2021 or equivalent guidelines; no study of whether guideline-consistent care changes patient outcomes.
Medical education interventions: No test of whether adding ME/CFS content to curricula changes diagnostic rates; no mandatory CME requirement in any jurisdiction.
Disability systems: No cross-national comparison of disability determination; no data on SSA claim outcomes for ME/CFS specifically; no employment retention intervention studies.
Equity: Healthcare disparities by race and geography documented but no intervention studies testing strategies to reduce them; no Global South data at all.
Pediatric-to-adult transition: No studied care model; no child-specific validated outcome measures.
De-stigmatization: Healthcare invalidation is documented as a harm mechanism; no intervention tested to reduce it in clinical settings.
(Evidence type: systematic gap analysis β no new primary data.)
Consequence: This inventory is not a criticism of the existing evidence β documentation of failure is a necessary first step. It is a warning: without filling these gaps, policy reform will remain aspirational. A health minister who wants to βfix ME/CFS careβ has no evidence to guide the decision between funding specialist clinics, mandating primary care education, or reforming disability adjudication β because no evidence distinguishes which lever has the largest effect. Severity applicability: the evidence gap affects all severity levels, but severe/very severe patients are the most affected by policy uncertainty, as they have the greatest need for functional care systems and the least capacity to navigate dysfunctional ones.